Cytodyn, Inc. (CYDY) Announces Manufacturing Agreement with Samsung Biologics for Leronlimab (PRO 140)

April 2, 2019 6:36 AM
CytoDyn Inc. (CYDY) today announced the execution of a comprehensive strategic agreement with Samsung BioLogics Co., Ltd. for the clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News Management Comments

Next Articles